
Enfortumab
CAS No. 1448664-46-7
Enfortumab( —— )
Catalog No. M36881 CAS No. 1448664-46-7
Enfortumab is a monoclonal antibody against Nectin-4.Enfortumab can be used to synthesize antibody-drug couplings (enfortumab vedotin) and can also be used in conjunction with platinum compounds to study uroepithelial cancers.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 439 | Get Quote |
![]() ![]() |
5MG | 591 | Get Quote |
![]() ![]() |
10MG | 947 | Get Quote |
![]() ![]() |
25MG | 1352 | Get Quote |
![]() ![]() |
50MG | 1831 | Get Quote |
![]() ![]() |
100MG | 2421 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameEnfortumab
-
NoteResearch use only, not for human use.
-
Brief DescriptionEnfortumab is a monoclonal antibody against Nectin-4.Enfortumab can be used to synthesize antibody-drug couplings (enfortumab vedotin) and can also be used in conjunction with platinum compounds to study uroepithelial cancers.
-
DescriptionEnfortumab is a monoclonal antibody targeting Nectin-4. Enfortumab can used for researching urothelial cancer.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorADC Antibody
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1448664-46-7
-
Formula WeightApproximately 143.9 kDa.
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Rosenberg JE, et al. Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy. J Clin Oncol. 2019;37(29):2592-2600.
molnova catalog



related products
-
Nuezhenide
Nuezhenide significantly protects human neuroblastoma SH-SY5Y cells from 6-hydroxydopamine-induced neurotoxicity.
-
Taraxeryl acetate
Taraxeryl acetate shows the significant antiviral activity against herpes simplex virus (type II). It has less effect on cell cycle arrest and apoptosis of AGS cells than taraxerol.
-
Mogroside I A1
Mogroside I A1 is a triterpenoid glycoside isolated from the extracts of Luo Han Guo, exhibiting antioxidant, antidiabetic and anticancer activities.